Targeted therapies and conventional care for the treatment of ankylosing spondylitis in China: a cost-effectiveness analysis based on the network-meta analysis

Abstract Objective This study aimed to evaluate the long-term cost-effectiveness of conventional care (CC) and seven first-line targeted therapies marketed in China for the treatment of patients with ankylosing spondylitis (AS)–namely secukinumab, ixekizumab, infliximab, etanercept, adalimumab and g...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jiaqi Shi, Wenxin Zhou, Tong Lin, Fengbo Wu, Ming Hu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-08-01
coleção:	Journal of Orthopaedic Surgery and Research
Assuntos:	Ankylosing spondylitis Biologicals Network-meta analysis Cost-effective
Acesso em linha:	https://doi.org/10.1186/s13018-024-04973-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!